NO20043610L - Fenylpyrimidinaminer som IgE inhibitorer - Google Patents
Fenylpyrimidinaminer som IgE inhibitorerInfo
- Publication number
- NO20043610L NO20043610L NO20043610A NO20043610A NO20043610L NO 20043610 L NO20043610 L NO 20043610L NO 20043610 A NO20043610 A NO 20043610A NO 20043610 A NO20043610 A NO 20043610A NO 20043610 L NO20043610 L NO 20043610L
- Authority
- NO
- Norway
- Prior art keywords
- phenylpyrimidinamines
- ige inhibitors
- ige
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0202381A GB0202381D0 (en) | 2002-02-01 | 2002-02-01 | Organic compounds |
GB0221953A GB0221953D0 (en) | 2002-09-20 | 2002-09-20 | Organic compounds |
PCT/EP2003/000973 WO2003063871A1 (en) | 2002-02-01 | 2003-01-31 | Phenylpyrimidine amines as ige inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20043610L true NO20043610L (no) | 2004-10-05 |
Family
ID=27665364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043610A NO20043610L (no) | 2002-02-01 | 2004-08-30 | Fenylpyrimidinaminer som IgE inhibitorer |
Country Status (23)
Country | Link |
---|---|
US (2) | US20050119255A1 (pt) |
EP (1) | EP1474146B1 (pt) |
JP (1) | JP4393198B2 (pt) |
KR (1) | KR20040081159A (pt) |
CN (2) | CN101684097A (pt) |
AR (1) | AR038368A1 (pt) |
AT (1) | ATE406165T1 (pt) |
AU (1) | AU2003206810B2 (pt) |
BR (1) | BR0307379A (pt) |
CA (1) | CA2471883C (pt) |
DE (1) | DE60323205D1 (pt) |
EC (1) | ECSP045213A (pt) |
ES (1) | ES2312749T3 (pt) |
IL (1) | IL162766A0 (pt) |
MX (1) | MXPA04007395A (pt) |
NO (1) | NO20043610L (pt) |
NZ (1) | NZ534229A (pt) |
PE (1) | PE20030983A1 (pt) |
PL (1) | PL370666A1 (pt) |
PT (1) | PT1474146E (pt) |
RU (1) | RU2004126614A (pt) |
TW (1) | TW200302728A (pt) |
WO (1) | WO2003063871A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
AU2004261484A1 (en) * | 2003-07-30 | 2005-02-10 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
JPWO2005040135A1 (ja) * | 2003-10-24 | 2007-03-08 | 小野薬品工業株式会社 | 抗ストレス薬およびその医薬用途 |
EP1933839A1 (en) * | 2005-09-29 | 2008-06-25 | Novartis AG | Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance |
JP5670731B2 (ja) | 2007-08-15 | 2015-02-18 | サイトキネティクス・インコーポレーテッドCytokinetics Incorporated | ある種の化学物質、組成物、および方法 |
AU2020407604A1 (en) | 2019-12-20 | 2022-07-21 | Ikena Oncology, Inc. | 4-phenyl-n-(phenyl)thiazol-2-amine derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of e.g. angiogenesis implicated or inflammatory disorders |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1185039A (en) | 1966-03-31 | 1970-03-18 | Ici Ltd | Pyrimidine Derivatives and Compositions containing them |
GB2001069B (en) | 1977-07-12 | 1982-01-20 | Scras | Pyrimidine derivatives |
AU5319479A (en) | 1978-12-22 | 1980-06-26 | Ici Australia Limited | Pyrimidinyl amino phenoxy carboxylate derivatives |
US4351939A (en) * | 1980-10-16 | 1982-09-28 | Mead Johnson & Company | Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process |
DE3270906D1 (en) * | 1982-01-14 | 1986-06-05 | Merck Patent Gmbh | Liquid crystal mixtures |
FR2536071B1 (fr) | 1982-11-12 | 1986-07-11 | Sanofi Sa | Sels acides de 2-piperazinopyrimidine, procede pour leur preparation et compositions pharmaceutiques en contenant |
FR2547821B1 (fr) * | 1983-06-24 | 1985-12-06 | Sanofi Sa | Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant |
US4659363A (en) | 1983-07-25 | 1987-04-21 | Ciba-Geigy Corporation | N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof |
EP0164204A1 (en) | 1984-05-12 | 1985-12-11 | FISONS plc | Novel pharmaceutically useful pyrimidines |
EP0172786B1 (de) * | 1984-06-25 | 1991-01-30 | Ciba-Geigy Ag | Pyrimidinderivate wirksam als Schädlingsbekämpfungsmittel |
ES2087056T3 (es) | 1986-01-13 | 1996-07-16 | American Cyanamid Co | 2-pirimidinaminas sustituidas en las posiciones 4, 5 y 6. |
DE3614060A1 (de) | 1986-04-23 | 1987-10-29 | Schering Ag | Pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
EP0254259A3 (en) | 1986-07-21 | 1989-11-23 | Otsuka Pharmaceutical Factory, Inc. | P-aminophenol derivatives |
DE3788494D1 (de) * | 1986-10-13 | 1994-01-27 | Ciba Geigy | Harnstoffe. |
US4826990A (en) | 1987-09-30 | 1989-05-02 | American Home Products Corporation | 2-aryl substituted heterocyclic compounds as antiallergic and antiinflammatory agents |
US4973690A (en) * | 1988-04-12 | 1990-11-27 | Ciba-Geigy Corporation | Novel ureas |
ES2058589T3 (es) * | 1988-04-12 | 1994-11-01 | Ciba Geigy Ag | Ureas. |
US4966622A (en) * | 1988-04-12 | 1990-10-30 | Ciba-Geigy Corporation | N-phenyl-N-pyrimidin-2-ylureas |
JPH02308248A (ja) * | 1989-05-24 | 1990-12-21 | Fuji Photo Film Co Ltd | アミノピリミジン系色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
US5521184A (en) * | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
WO1995009853A1 (en) | 1993-10-01 | 1995-04-13 | Ciba-Geigy Ag | Pharmacologically active pyridine derivatives and processes for the preparation thereof |
ATE325113T1 (de) | 1993-10-01 | 2006-06-15 | Novartis Pharma Gmbh | Pharmacologisch wirksame pyrimidinderivate und verfahren zu deren herstellung |
US5612340A (en) | 1993-10-01 | 1997-03-18 | Ciba-Geigy Corporation | Pyrimidineamine derivatives and processes for the preparation thereof |
NZ274978A (en) * | 1993-10-12 | 1998-04-27 | Du Pont Merck Pharma | 1n-alkyl-n-aryl pyrimidinamine derivatives and pharmaceutical compositions thereof |
DE69530989T2 (de) | 1994-08-13 | 2004-05-19 | Yuhan Corp. | Neue pyrimidinderivate und verfahren zu ihrer herstellung |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
WO1998024782A2 (en) | 1996-12-05 | 1998-06-11 | Amgen Inc. | Substituted pyrimidine compounds and their use |
US6187781B1 (en) * | 1997-03-26 | 2001-02-13 | Taisho Pharmaceutical Co., Ltd. | 4-Tetrahydropyridylpyrimidine derivatives |
IN188411B (pt) | 1997-03-27 | 2002-09-21 | Yuhan Corp | |
US6440965B1 (en) | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
AU2516199A (en) * | 1998-01-12 | 1999-07-26 | Novartis Ag | Pyridinylpyrimidine amines as immunoglobuline e (ige) synthesis inhibitors |
WO1999038829A1 (fr) * | 1998-01-28 | 1999-08-05 | Shionogi & Co., Ltd. | Nouveau compose tricyclique |
ES2193660T3 (es) | 1998-03-27 | 2003-11-01 | Janssen Pharmaceutica Nv | Derivados de pirimidina inhibidores de vih. |
AR023052A1 (es) | 1998-09-25 | 2002-09-04 | Mitsuharu Yoshimura Milton | Derivados de pirimidona |
SK286264B6 (sk) * | 1998-11-17 | 2008-06-06 | Kumiai Chemical Industry Co., Ltd. | Derivát pyrimidinylbenzimidazolu alebo triazinylbenzimidazolu, medziprodukty na jeho prípravu a poľnohospodársky/záhradnícky fungicíd s jeho obsahom |
GB9828511D0 (en) | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
EP1180520B1 (en) | 1999-04-28 | 2007-06-20 | Institute of Medicinal Molecular Design, Inc. | Pyrimidine carboxylic acid derivatives |
GB9914258D0 (en) | 1999-06-18 | 1999-08-18 | Celltech Therapeutics Ltd | Chemical compounds |
GB0003224D0 (en) | 2000-02-11 | 2000-04-05 | Glaxo Group Ltd | Chemical compounds |
-
2003
- 2003-01-30 TW TW092102250A patent/TW200302728A/zh unknown
- 2003-01-30 AR ARP030100267A patent/AR038368A1/es not_active Application Discontinuation
- 2003-01-31 AU AU2003206810A patent/AU2003206810B2/en not_active Ceased
- 2003-01-31 NZ NZ534229A patent/NZ534229A/en unknown
- 2003-01-31 AT AT03704506T patent/ATE406165T1/de active
- 2003-01-31 MX MXPA04007395A patent/MXPA04007395A/es active IP Right Grant
- 2003-01-31 PE PE2003000116A patent/PE20030983A1/es not_active Application Discontinuation
- 2003-01-31 CA CA2471883A patent/CA2471883C/en not_active Expired - Fee Related
- 2003-01-31 US US10/501,445 patent/US20050119255A1/en not_active Abandoned
- 2003-01-31 JP JP2003563561A patent/JP4393198B2/ja not_active Expired - Fee Related
- 2003-01-31 WO PCT/EP2003/000973 patent/WO2003063871A1/en active IP Right Grant
- 2003-01-31 IL IL16276603A patent/IL162766A0/xx unknown
- 2003-01-31 CN CN200910205037A patent/CN101684097A/zh active Pending
- 2003-01-31 PL PL03370666A patent/PL370666A1/xx not_active Application Discontinuation
- 2003-01-31 PT PT03704506T patent/PT1474146E/pt unknown
- 2003-01-31 BR BR0307379-3A patent/BR0307379A/pt not_active IP Right Cessation
- 2003-01-31 RU RU2004126614/04A patent/RU2004126614A/ru not_active Application Discontinuation
- 2003-01-31 EP EP03704506A patent/EP1474146B1/en not_active Expired - Lifetime
- 2003-01-31 KR KR10-2004-7011797A patent/KR20040081159A/ko not_active Application Discontinuation
- 2003-01-31 CN CNA038027372A patent/CN1622807A/zh active Pending
- 2003-01-31 DE DE60323205T patent/DE60323205D1/de not_active Expired - Fee Related
- 2003-01-31 ES ES03704506T patent/ES2312749T3/es not_active Expired - Lifetime
-
2004
- 2004-07-30 EC EC2004005213A patent/ECSP045213A/es unknown
- 2004-08-30 NO NO20043610A patent/NO20043610L/no not_active Application Discontinuation
-
2007
- 2007-05-23 US US11/805,515 patent/US7759357B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7759357B2 (en) | 2010-07-20 |
KR20040081159A (ko) | 2004-09-20 |
US20070281956A1 (en) | 2007-12-06 |
NZ534229A (en) | 2005-04-29 |
US20050119255A1 (en) | 2005-06-02 |
RU2004126614A (ru) | 2005-05-27 |
IL162766A0 (en) | 2005-11-20 |
PE20030983A1 (es) | 2004-01-26 |
BR0307379A (pt) | 2004-12-28 |
CA2471883C (en) | 2010-12-07 |
EP1474146B1 (en) | 2008-08-27 |
CN1622807A (zh) | 2005-06-01 |
AR038368A1 (es) | 2005-01-12 |
CN101684097A (zh) | 2010-03-31 |
DE60323205D1 (en) | 2008-10-09 |
ES2312749T3 (es) | 2009-03-01 |
JP2005516051A (ja) | 2005-06-02 |
PT1474146E (pt) | 2008-12-05 |
EP1474146A1 (en) | 2004-11-10 |
ATE406165T1 (de) | 2008-09-15 |
JP4393198B2 (ja) | 2010-01-06 |
TW200302728A (en) | 2003-08-16 |
AU2003206810B2 (en) | 2006-06-29 |
MXPA04007395A (es) | 2005-06-17 |
PL370666A1 (en) | 2005-05-30 |
WO2003063871A1 (en) | 2003-08-07 |
CA2471883A1 (en) | 2003-08-07 |
ECSP045213A (es) | 2004-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1492785T3 (da) | 2-hydroxy-3-heteroarylindol-derivater som GSK3-inhibitorer | |
NO20055680D0 (no) | Heksahydropyridoisokinoliner som DPP-IV-inhibitorer | |
NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
NO20044654L (no) | Piperidinoylpiperidiner som 5-HTIF-agonister | |
DE602004018837D1 (de) | Ptidase-iv-inhibitoren | |
ATE457980T1 (de) | Aryloxime | |
ATE534648T1 (de) | C-6-modifizierte indazolylpyrrolotriazine | |
ATE427876T1 (de) | Luftkissenboot | |
ATE318817T1 (de) | Aza-arylpiperazine | |
ATE349458T1 (de) | Etonogestrelester | |
DE60218856D1 (de) | Münzspeichermessung | |
DK1492934T3 (da) | Dørenhed | |
ATA1572002A (de) | Managementspleisskassette | |
DK1499622T3 (da) | Meterotricyclyl-6-alkylidenpenemer som beta-lactamaseinhibitorer | |
DE60316425D1 (de) | NF-kappaB-INHIBITOREN | |
NO20043610L (no) | Fenylpyrimidinaminer som IgE inhibitorer | |
ATA4142004A (de) | Trägerverbau | |
ATE469773T1 (de) | Zugöse | |
ATE396192T1 (de) | N-sulfonylaminothiazole | |
ITMI20021327A1 (it) | Nuove ossialchilpiperazine | |
DE10244834B8 (de) | Suszeptometer | |
AT5889U3 (de) | Brennholzspleisser | |
ATA16872002A (de) | Zwischenstück | |
DE10211707A8 (de) | Segmentstatormaschine | |
NO20044043L (no) | Dipyridodiazepioner som revers-transkriptase-inhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |